Angel Biotechnology Holdings (LSE:ABH) Total Current Assets: £1.20 Mil (As of Sep. 2012)


What is Angel Biotechnology Holdings Total Current Assets?

Angel Biotechnology Holdings LSE:ABH Total Current Assets is £1.20 Mil as of Sep. 2012. The stock has 2 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Angel Biotechnology Holdings's total current assets for the quarter that ended in Sep. 2012 was £1.20 Mil.


Angel Biotechnology Holdings  (LSE:ABH) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Angel Biotechnology Holdings's Liquidation Value for the quarter that ended in Sep. 2012 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.496-2.599+0.75 * 0+0.5 * 0
=-2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Angel Biotechnology Holdings Total Current Assets Related Terms


Angel Biotechnology Holdings Total Current Assets Historical Data

* Premium members only.

The historical data trend for Angel Biotechnology Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angel Biotechnology Holdings Total Current Assets Chart

Angel Biotechnology Holdings Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec07 Dec08 Dec09 Dec10 Mar12
Total Current Assets
Get a 7-Day Free Trial Premium Member Only 0.17 0.27 0.30 1.15 1.71

Angel Biotechnology Holdings Semi-Annual Data
Jun05 Dec05 Jun06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Mar12 Sep12
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.15 1.53 1.71 1.20

Angel Biotechnology Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Angel Biotechnology Holdings's Total Current Assets for the fiscal year that ended in Mar. 2012 is calculated as

Angel Biotechnology Holdings's Total Current Assets for the quarter that ended in Sep. 2012 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of £1.20 Mil mean?
Angel Biotechnology Holdings (LSE:ABH) has a Total Current Assets of £1.20 Mil as of Sep. 2012. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Angel Biotechnology Holdings and its competitors.
Is Angel Biotechnology Holdings' Total Current Assets too high?
Angel Biotechnology Holdings' current Total Current Assets is £1.20 Mil.
How does Angel Biotechnology Holdings' Total Current Assets compare to competitors?
Angel Biotechnology Holdings' Total Current Assets of £1.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Angel Biotechnology Holdings and its competitors. Angel Biotechnology Holdings's current Total Current Assets is £1.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angel Biotechnology Holdings stock overvalued right now?
Angel Biotechnology Holdings (LSE:ABH) has a current Total Current Assets of £1.20 Mil. The current Total Current Assets is £1.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Angel Biotechnology Holdings (LSE:ABH), the current Total Current Assets is £1.20 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.